A Single-Institution Phase Ii Trial of Radiation (Rt), Temozolomide (Tmz), Erlotinib, and Bevacizumab for Initial Treatment of Glioblastoma (Gbm)

AuthID
 P-005-EWV
11
Author(s)
Clarke, JL
·
Molinaro, AM
·
Chang, SM
·
Phillips, JJ
·
Costa, BM
·
Costello, JF
·
Rabbitt, JE
·
Kivett, VA
·
DeSilva, AA
·
Prados, M
Document Type
Abstract
Year published
2012
Published
in JOURNAL OF CLINICAL ONCOLOGY, ISSN: 0732-183X
Volume: 30, Issue: 15
Conference
48Th Annual Meeting of the American-Society-Of-Clinical-Oncology (Asco), Date: JUN 01-06, 2012, Location: Chicago, IL, Sponsors: Amer Soc Clin Oncol (ASCO)
Indexing
Wos®
Publication Identifiers
Wos: WOS:000318009801473
Source Identifiers
ISSN: 0732-183X
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.

A place for researchers and their institutions

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service